The effect of simvastatin on serum cytokine levels in patients with acute myocardial infarction

Wang Zhijian,Li Meihong,Chen Saiyong

DOI: https://doi.org/10.3969/j.issn.1007-9688.2006.02.006

2006-01-01

Abstract:Objectives To examine the levels of serum tumor necrosis factor-α (TNF-α), interleukins-6 (IL-6)and C reactive protein(CRP), and the effects of simvastatin on the production of the cytokines in peripheral blood mononuclear cells (PBMC) in patients with acute myocardial infarction(AMI). Methods The serum levels of TNF-α, IL-6 and CRP were detected in 93 patients with stable coronary heart disease(control group)and 102 patients with AMI. PBMC were cultured with 0 μmol/L, 0.1 μmol/L, 1.0 μmol/L and 10 μmol/L of simvastatin in the presence of lipopoly sacchardic after 48 hour incubation,TNF-α and IL-6 were measured in the culture supernatants by an ELISA. Results Compared with controls group, AMI patients had increased serum levels of TNF-α, IL-6 and CRP(P<0.01=. The higher the upgrading of killip class, the higher the levels of TNF-α, IL-6 and CRP(P<0.01=. TNF-α positively correlated with IL-6(r=0.61 P<0.01=. The production of TNF-α and IL-6 were significantly inhibited by simvastatin in both groups in a dose-depended manner. Conclusions In AMI patients, the levels of serum TNF-α, IL-6 and CRP were significantly increased. Simvastatin can modulate the levels of serum TNF-α and IL-6 in AMI patients.